Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) - CITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE
Navigation: NDC > Supplier starting with: H > HAEMONETICS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 57826-455 |
| Proprietary Name: | Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) |
| Suffix: | |
| Non-Proprietary Name: | CITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE |
| Dosage Form: | SOLUTION |
| Method: | EXTRACORPOREAL |
| Original Marketing Date: | 10-01-2013 |
| Category Name: | BLA |
| Application Number: | BLA000127 |
| Labeler: | HAEMONETICS CORPORATION |
| Substance Name: | ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Active Numerator Strength: | 464; 32.7; 22.2; 263 |
| Active Ingredient Unit: | mg/mL; mg/mL; mg/mL; mg/mL |
| Pharm Classes: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| DEA Schedule: |